04/26/2024
3:16 PM | Pyxis Oncology (Filer)
| Form ARS | |
04/26/2024
3:15 PM | Pyxis Oncology (Filer)
| Form DEF 14A | |
04/26/2024
3:16 PM | Pyxis Oncology (Filer)
| Form DEFA14A | |
04/03/2024
11:15 PM | Pyxis Oncology (Filer)
| Form EFFECT | |
03/28/2024
3:31 PM | Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:32 PM | Civik Thomas (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:32 PM | HUMPHREY RACHEL (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/28/2024
3:33 PM | Cline Darren S (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:33 PM | Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:33 PM | Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
6:49 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:44 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:54 PM | Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:45 PM | Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/13/2024
3:31 PM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:02 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:28 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pyxis Oncology (Subject)
| Form SC 13G/A | |
12/29/2023
3:33 PM | Kobayashi Ken (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
3:50 PM | Kobayashi Ken (Reporting)
Pyxis Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/28/2023
6:22 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:44 PM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:46 PM | Pyxis Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023
3:34 PM | Pyxis Oncology (Filer)
| Form 8-K/A | |
09/28/2023
3:32 PM | Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2023
5:36 PM | Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2023
5:37 PM | Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2023
6:04 PM | Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
4:05 PM | Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
4:04 PM | Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:34 PM | Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:35 PM | Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
6:03 PM | Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:26 PM | Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
3:43 PM | Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
7:16 PM | Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
3:47 PM | Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
3:35 PM | Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
3:46 PM | Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
4:08 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2023
4:28 PM | Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/25/2023
4:30 PM | Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Guard Against the Coming Financial Upheaval (Ad) America’s Most Shocking Financial Story…
Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late. You can stream it for free right here. |
08/24/2023
11:15 PM | Pyxis Oncology (Filer)
| Form EFFECT | |
08/23/2023
4:28 PM | Pyxis Oncology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/23/2023
4:28 PM | Pyxis Oncology (Filer)
| Form POS AM | |
08/23/2023
4:30 PM | Pyxis Oncology (Filer)
| Form S-8 POS | |
08/23/2023
7:47 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
4:00 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023
6:25 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
6:26 AM | Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
| Form 425 | |
08/11/2023
6:31 AM | Pyxis Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023
5:34 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
5:35 AM | Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
| Form 425 | |
07/31/2023
3:41 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/28/2023
9:18 AM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144/A | |
07/21/2023
3:27 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2023
12:27 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2023
11:15 PM | Pyxis Oncology (Filer)
| Form EFFECT | |
06/30/2023
3:30 PM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:31 PM | Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
| Form 425 | |
06/16/2023
2:22 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
7:03 AM | Pyxis Oncology (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
06/07/2023
6:12 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2023
3:41 PM | Pyxis Oncology (Subject)
| Form 425 | |
05/25/2023
7:14 AM | Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
| Form 425 | |
05/24/2023
5:59 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
6:03 AM | Pyxis Oncology (Subject)
| Form 425 | |
05/24/2023
6:05 AM | Apexigen, Inc. (Filed by)
Apexigen, Inc. (Filed by)
Apexigen, Inc. (Filed by)
Pyxis Oncology (Subject)
| Form 425 | |
